4th Quarter - Report
CAPITOL SOLUTIONS for AMGEN USA
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1956, To amend the Public Health Services Act to provide for the approval of similar biological products H.R. 1038, To provide for the licensing of comparable and interchangable biological products H.R. 5629, To establish a pathway for licensure of biosimilars biological products
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CURTIS | — |
| DANIEL C TATE | — |
Medicare/Medicaid MMM
Issues regarding Medicare payments
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CURTIS | — |
| DANIEL C TATE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.